• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: Suven Life Sciences is negotiating with three US companies for new business opportunities in Phase II and Phase III clinical trials.

The Hyderabad-based company has discovered new business opportunity in DDDSS (Drug Discovery and Development Support Services), a Phase II clinical trial reporting to the USFDA, for an oncology product of a US company.

In a press release here, Suven said this was its second contract within eight months of launching the DDDSS business model in January 2005.

The company was positioning itself as a collaborative research partner for global life sciences companies, a press release said.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
ONGC begins salvage operations at Bombay High

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line